当前位置： SCI文献检索 > THROMBOSIS AND HAEMOSTASIS期刊下所有文献 > Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.

Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.

Abstract：

:We have developed a simple assay that measures the circulating activated protein C (APC) in plasma. The assay requires collection of duplicate blood samples, one in citrate plus heparin and the other in citrate plus inhibitors of the enzyme. In the heparin tube, APC reacts completely and irreversibly with its major plasma inhibitors, protein C inhibitor (PCI) and alpha 1-antitrypsin (alpha 1AT), and the complexes formed are measured by ELISAs. The amount of circulating APC is calculated from the difference between the total amount of complexed APC (sample in citrate plus heparin) and the amount of APC complexed in vivo (sample in citrate plus inhibitor). Over 95% of the APC added to blood collected with heparin was recovered in the assay. The assay can easily be performed in four hours, and had a detection limit of 0.1 ng/ml APC. The mean APC level in 18 protein C heterozygous members from seven kindreds was significantly lower (0.6 +/- 0.3 ng/ml) than in 20 healthy controls (1.1 +/- 0.3 ng/ml) (p < 0.001), whereas the mean level in 10 non-affected members from the kindreds studied was 1.5 +/- 0.3 ng/ml. In the group of 12 nonanticoagulated heterozygous protein C-deficient individuals, the three patients with a history of venous thrombosis had a mean APC level significantly lower than the nine asymptomatic members (p < 0.01), both subgroups showing similar protein C levels. There was a significant correlation in all groups between the levels of APC and the levels of protein C antigen (r = 0.758, p < 0.0001) and activity (r = 0.745, p < 0.0001), which means that APC circulating levels are proportional to protein C levels and suggests that the protein C level is the limiting factor in the rate of protein C activation in vivo.

journal_name

Thromb Haemost

journal_title

Thrombosis and haemostasis

authors

Espana F,Zuazu I,Vicente V,Estellés A,Marco P,Aznar J

subject

Has Abstract

pub_date

1996-01-01 00:00:00

pages

56-61

issue

1

eissn

0340-6245

issn

2567-689X

journal_volume

75

pub_type

杂志文章

相关文献

THROMBOSIS AND HAEMOSTASIS文献大全
  • Differentiation of Patients with Symptomatic Low von Willebrand Factor from Those with Asymptomatic Low von Willebrand Factor.

    abstract：BACKGROUND: Accurate diagnosis of symptomatic low von Willebrand factor (VWF) remains a major challenge in von Willebrand disease (VWD). However, present tests do not adequately take into account flow forces that, at very high shear rates, reveal a weakness in the VWF-platelet glycoprotein glycoprotein Ib bond in norma...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1055/s-0040-1709525

    authors： Grabowski EF,Van Cott EM,Bornikova L,Boyle DC,Silva RL

    更新日期：2020-05-01 00:00:00

  • Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.

    abstract：:In trauma patients, resuscitation treatment of intravascular volume may cause haemodilution including blood cell- and plasma-dilution. After plasma-dilution, fibrinogen is the first factor that decreases to critically low concentrations. Fibrin formed in lowered levels is susceptible to fibrinolysis, a natural forerun...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH13-06-0497

    authors： He S,Johnsson H,Zabczyk M,Hultenby K,Wallén H,Blombäck M

    更新日期：2014-03-03 00:00:00

  • Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.

    abstract：:Tissue factor (TF) is the blood coagulation initiator, whose cofactor function is required for physiological factor VIIa (FVIIa)-mediated activation of factor X (FX) to FXa. A previous study reported TF on herpes simplex virus type 1 (HSV1), but this explained only part of FVIIa-dependent FXa generation observed on th...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH04-04-0242

    authors： Sutherland MR,Friedman HM,Pryzdial EL

    更新日期：2004-11-01 00:00:00

  • F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.

    abstract：:Congenital factor VII (FVII) deficiency is a rare bleeding disorder caused by mutations in F7 gene with autosomal recessive inheritance. A clinical heterogeneity with poor correlation with FVII:C levels has been described. It was the objective of this study to identify genetic defects and to evaluate their relationshi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章,多中心研究

    doi：10.1160/TH17-02-0085

    authors： Quintavalle G,Riccardi F,Rivolta GF,Martorana D,Di Perna C,Percesepe A,Tagliaferri A,Ad-Hoc Study Group.

    更新日期：2017-08-01 00:00:00

  • Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.

    abstract：:Tissue factor (TF) plays a pivotal role in thrombus formation and atherogenesis in acute coronary syndrome. Tissue factor pathway inhibitor (TFPI) is a specific physiological inhibitor of TF/FVIIa complex that regulates TF-induced coagulation. Adiponectin (Adp) is an adipocyte-specific adipocytokine with anti-atheroge...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Chen YJ,Zhang LQ,Wang GP,Zeng H,Lü B,Shen XL,Jiang ZP,Chen FP

    更新日期：2008-08-01 00:00:00

  • Abnormal aggregation and increased size of platelets in myeloproliferative disorders.

    abstract：:Platelet aggregation is frequently impaired in myeloproliferative disorders (MPD). The presence of spontaneous platelet aggregation (SPA) or alterations of the aggregation pattern after ADP, epinephrine and collagen have been a frequent feature in the series of 52 patients here presented. The occurrence of SPA was not...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Cortelazzo S,Barbui T,Bassan R,Dini E

    更新日期：1980-06-18 00:00:00

  • ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression.

    abstract：:Abdominal aortic aneurysm (AAA) evolution is unpredictable, and there is no therapy except surgery for patients with an aortic size> 5 cm (large AAA). We aimed to identify new potential biomarkers that could facilitate prognosis and treatment of patients with AAA. A differential quantitative proteomic analysis of plas...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH14-10-0874

    authors： Burillo E,Lindholt JS,Molina-Sánchez P,Jorge I,Martinez-Pinna R,Blanco-Colio LM,Tarin C,Torres-Fonseca MM,Esteban M,Laustsen J,Ramos-Mozo P,Calvo E,Lopez JA,Vega de Ceniga M,Michel JB,Egido J,Andrés V,Vazquéz J,Meilha

    更新日期：2015-06-01 00:00:00

  • Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.

    abstract：:An assay for the quantification of pentosan polysulphate (PPS) in plasma is described. As PPS has been shown to potentiate thrombin inhibition by the second heparin cofactor (HC II), the principle of this assay was to measure the formation of covalent complexes between HC II and the thrombin generated in plasma after ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Dol F,Sié P,Dupouy D,Boneu B

    更新日期：1986-12-15 00:00:00

  • Proteolytic and immunologic comparison of human and bovine von Willebrand factor.

    abstract：:The structures of bovine and human vWF were compared by proteolysis with Staphylococcus aureus V8 protease and rattlesnake venom Protease I. Fragments were analyzed for chain composition, heparin binding, collagen binding, platelet agglutinating activity and recognition by a panel of monoclonal antibodies which reacte...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Bakhshi MR,Kirby EP

    更新日期：1990-06-28 00:00:00

  • Antibodies against fibrinogen in pregnant women, in post delivery women and in the newborns.

    abstract：:Pregnancy and delivery have measurable effects on haemostatic and immunological changes. Degradation of fibrinogen induces significant structural and conformational modulation and leads to the progressive loss of antigenic sites present on the parent molecule but also exposes some new sites. These neoantigens may be r...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Kondera-Anasz Z

    更新日期：1998-05-01 00:00:00

  • Effect of thrombin on phosphorylation of platelet membrane proteins.

    abstract：:The effect of thrombin on the phosphorylating activity of platelet membranes was compared to that of trypsin. Preincubation of non-32P phosphorylated platelet membranes with or without either of these two enzymes resulted in a considerable loss of membrane protein kinase activity which was most severe when trypsin was...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Steiner M

    更新日期：1976-06-30 00:00:00

  • Human thrombi contain an abundance of active thrombin.

    abstract：:This study assessed the abundance and activity of thrombin in human thrombi. removed at autopsy or during surgery. Arterial and venous thrombus sections showed thrombin activity by in situ zymography, based on conversion of fibrinogen to fibrin. Hirudin or antibodies to thrombin abolished the activity. Thrombin activi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Mutch NJ,Robbie LA,Booth NA

    更新日期：2001-10-01 00:00:00

  • Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.

    abstract：:In patients with myeloproliferative disorders (MPD) a group of related diseases of the bone marrow stem cell and recurrent haemorrhagic and/or thrombotic complications, the production of aggregating prostaglandins (PGs) may be normal or slightly reduced, while PGI2 production is normal. However, MPD platelet sensitivi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Cortelazzo S,Galli M,Castagna D,Viero P,de Gaetano G,Barbui T

    更新日期：1988-02-25 00:00:00

  • Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT.

    abstract：:Forty-eight patients with acute proximal deep vein thrombosis (DVT) were randomised to intravenous infusions for 4 to 6 days with melagatran, a novel synthetic low molecular weight thrombin inhibitor, or unfractionated heparin adjusted by the activated partial thromboplastin time (APTT). The aim of the study was to in...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：

    authors： Eriksson H,Eriksson UG,Frison L,Hansson PO,Held P,Holmström M,Hägg A,Jonsson T,Lapidus L,Leijd B,Stockelberg D,Säfwenberg U,Taghavi A,Thorsén M

    更新日期：1999-03-01 00:00:00

  • Plasminogen activator and plasminogen activator inhibitor associated with granulomatous inflammation: a study with murine leprosy.

    abstract：:Plasminogen activator that is associated with the development of hypersensitivity granulomas (gPA) was partially purified from a saline soluble fraction of murine lepromas elicited in "resistant" mice, C57BL/6N. The gPA was shown to consist of two subspecies (23,000 and 48,000 in molecular weight) with essentially ide...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Izaki S,Hibino T,Isozaki Y,Hsu PS,Izaki M,Matsuo O

    更新日期：1984-12-29 00:00:00

  • The effects of standard and low molecular weight heparin on bone nodule formation in vitro.

    abstract：:Previously, we demonstrated in a rat model of heparin-induced osteoporosis that low molecular weight heparin (LMWH) produces less bone loss than unfractionated heparin, and that only heparin increases osteoclast number and activity. In contrast, both heparin and LMWH were found to decrease osteoblast function to a sim...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Bhandari M,Hirsh J,Weitz JI,Young E,Venner TJ,Shaughnessy SG

    更新日期：1998-09-01 00:00:00

  • Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.

    abstract：:Thrombotic complications are frequently associated with atherosclerosis. Lysophosphatidylcholine (LPC), a component accumulated in oxidatively modified LDL (ox-LDL), is known to play a crucial role in the initiation and progression of atherosclerotic vascular lesions. Since a vascular anticoagulant, tissue factor path...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Sato N,Kokame K,Miyata T,Kato H

    更新日期：1998-01-01 00:00:00

  • Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study.

    abstract：:Limited data exist on thrombophilia and the risk of venous thrombosis (VT) during pregnancy and postpartum. The objectives of the present study were to investigate the role of haemostatic risk factors for pregnancy-related VT and their phenotypic expression in deep-vein thrombosis (DVT) and pulmonary embolism (PE). To...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH12-05-0350

    authors： Bergrem A,Dahm AE,Jacobsen AF,Sandvik L,Sandset PM

    更新日期：2012-12-01 00:00:00

  • Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery.

    abstract：:Subcutaneous heparin is the treatment of choice for women requiring anticoagulant therapy during pregnancy. However, heparin therapy presents a management problem at delivery because of its potential to cause a persistent anticoagulant effect and thus increase the risk of bleeding. In order to avoid therapeutic compli...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Anderson DR,Ginsberg JS,Burrows R,Brill-Edwards P

    更新日期：1991-03-04 00:00:00

  • Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.

    abstract：:The influence of changes in liver blood flow on the clearance of rt-PA was studied both in healthy subjects and in a perfused rat liver model. Liver blood flow in healthy subjects was documented indirectly by the clearance of indocyanine green (ICG). Exercise reduced liver blood flow on average by 57% with a 95% confi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： de Boer A,Kluft C,Kroon JM,Kasper FJ,Schoemaker HC,Pruis J,Breimer DD,Soons PA,Emeis JJ,Cohen AF

    更新日期：1992-01-23 00:00:00

  • Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin).

    abstract：:Central venous access devices are often essential for the administration of chemotherapy to patients with malignancy, but its use has been associated with a number of complications, mainly thrombosis. The true incidence of upper extremity deep vein thrombosis (DVT) in this setting is difficult to estimate since there ...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Monreal M,Alastrue A,Rull M,Mira X,Muxart J,Rosell R,Abad A

    更新日期：1996-02-01 00:00:00

  • Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.

    abstract：:We performed experiments to determine whether endothelial cells synthesize phospholipid metabolites via the lipoxygenase pathway and whether these metabolites influence platelet/vessel wall interactions. Monolayers of cultured human endothelial cells were incubated with 14C-arachidonic acid and their cyclo-oxygenase a...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Buchanan MR,Butt RW,Magas Z,van Ryn J,Hirsh J,Nazir DJ

    更新日期：1985-06-24 00:00:00

  • Additive effect of dDAVP and standard heparin in increasing plasma t-PA.

    abstract：:The aim of this study was to evaluate the existence of an additive effect between standard heparin and dDAVP in the enhancement of endogenous fibrinolysis. Eight healthy volunteers were studied in a randomized double blind placebo controlled cross-over trial. The volunteers were treated i.v. with dDAVP, 0.4 micrograms...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Agnelli G,Levi M,Cosmi B,ten Cate JW,Nenci GG

    更新日期：1989-06-30 00:00:00

  • Thrombophilic risk factors and peripheral arterial disease severity.

    abstract：:Few data are available on thrombophilic risk factors and progression of atherosclerotic peripheral arterial disease (PAD). Thrombophilic alterations can be an aggravating factor when arterial stenoses are present. In a cross-sectional study, we evaluated the presence of the thrombophilic factors fibrinogen, homocystei...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH09-11-0772

    authors： Sartori M,Favaretto E,Legnani C,Cini M,Conti E,Amato A,Palareti G

    更新日期：2010-07-01 00:00:00

  • Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

    abstract：:In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an elective surgery/procedure, the risks and benefits of perioperative bridging anticoagulation is uncertain.We accessed the database from RE-LY, a randomised trial comparing dabigatran with warfarin for stroke prevention ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH14-04-0305

    authors： Douketis JD,Healey JS,Brueckmann M,Eikelboom JW,Ezekowitz MD,Fraessdorf M,Noack H,Oldgren J,Reilly P,Spyropoulos AC,Wallentin L,Connolly SJ

    更新日期：2015-03-01 00:00:00

  • An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.

    abstract：:A factor VIII inhibitor has been found in a patient with an unusual combination of factor VIII-related properties. The inhibitor is directed specifically against the clotting activity (VIII:C) of the factor VIII complex. It behaves in a similar fashion to high responding inhibitors of factor VIII seen in haemophilia A...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Taylor LD,Dean FL,Tiedemann K,Ekert H

    更新日期：1986-04-30 00:00:00

  • Turnover study of heparin cofactor II in healthy man.

    abstract：:Heparin cofactor II (HC II) is a heparin-dependent inhibitor of thrombin, distinct from antithrombin III (AT III). This study was designed to evaluate its metabolism in healthy subjects. Purified HC II was labelled with 125I by the lactoperoxidase-glucose oxidase technique. The biological activity of the HC II was unc...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Sié P,Dupouy D,Pichon J,Boneu B

    更新日期：1985-10-30 00:00:00

  • The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers.

    abstract：:Three single nucleotide polymorphisms (-603A/G, -1322C/T, -1812C/T) and one deletion/insertion polymorphism (-1208D/I) are present in the tissue factor (TF) gene promoter sequence. These polymorphisms are in complete linkage disequilibrium, determining two haplotypes with almost equal frequency. The -603A/-1208D/-1322...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH03-09-0566

    authors： Reny JL,Laurendeau I,Fontana P,Bièche I,Dupont A,Remones V,Emmerich J,Vidaud M,Aiach M,Gaussem P

    更新日期：2004-02-01 00:00:00

  • Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.

    abstract：:Malondialdehyde (MDA) is a stable produce of arachidonic acid metabolism, catalyzed by the enzyme cyclo-oxygenase. The experimental conditions for measuring the kinetics of MDA formation in rat citrated platelet-rich plasma were defined. Platelets were stimulated with either arachidonic acid, the substrate of MDA, or ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Rajtar G,Livio M,Merino J,de Gaetano G

    更新日期：1980-10-31 00:00:00

  • Heparin reverses the procoagulant properties of stimulated endothelial cells.

    abstract：:We examined the ability of unfractionated heparin to modulate the procoagulant activities of stimulated endothelial cells (EC). Confluent human venous umbilical EC were incubated with heparin before or after stimulation, then rinsed extensively to eliminate any heparin in the solution. EC, stimulated for 4 h with endo...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Cadroy Y,Gaspin D,Dupouy D,Lormeau JC,Boneu B,Sié P

    更新日期：1996-01-01 00:00:00